Remus Pharmaceuticals Ltd.
REMUS
Remus Pharmaceuticals Ltd.
REMUS
Remus Pharmaceuticals Ltd. Share Price
925.00 +14.85 (+1.63%)Fundamentals
Market Cap₹1,063Cr | EPS₹39.19 |
P/E Ratio (TTM)25.48 | Industry P/E (TTM)45.66 |
P/B Ratio4.19 | Long Term D/E0.07 |
ROE12.19% | Dividend Yield (TTM)0.10% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Outperformer
Good Quality
Slight Price Fluctuation
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Remus Pharmaceuticals Ltd.
The share price of Remus Pharmaceuticals Ltd. is ₹925.00 on NSE as of 29/8/2026, 12:02:53 am. Share prices may change frequently due to market movements.
The market capitalisation of Remus Pharmaceuticals Ltd. is ₹1,063Cr as of 29/8/2026, 12:02:53 am
The current Price to Earnings (P/E) ratio of Remus Pharmaceuticals Ltd. is 25.48 as of 29/8/2026, 12:02:53 am
The Price to Book (P/B) ratio of Remus Pharmaceuticals Ltd. stands at 4.19 as of 29/8/2026, 12:02:53 am
Remus Pharmaceuticals Ltd. reported an ROE of 12.19% for the last reported financial year on a consolidated account basis.
As of 29/8/2026, 12:02:53 am, Remus Pharmaceuticals Ltd.’s shareholding pattern is: promoters hold 71.00%, FIIs hold 5.30%, DIIs hold 0.80%, and public shareholders hold 22.90%.
The 52-week high of Remus Pharmaceuticals Ltd. is ₹931.00 and the 52-week low is ₹902.10 as of 29/8/2026, 12:02:53 am.
The stock symbol of Remus Pharmaceuticals Ltd. is REMUS.
You can buy Remus Pharmaceuticals Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Remus Pharmaceuticals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Y/Y Change |
|---|---|---|
| Operating Revenue | 853.63 | +37.60% |
| Other Income | 6.70 | +34.54% |
| Total Income | 860.33 | +37.58% |
| Total Expenditure | 801.17 | +38.61% |
| EBIDT | 63.39 | +25.10% |
| Depreciation | 2.76 | +47.59% |
| Interest | 1.47 | +0.68% |
| Tax | 12.99 | +45.63% |
| Net Profit | 36.99 | +27.24% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 294.64 |
| Total Non-Current Assets | 284.01 |
| Fixed assets | 18.04 |
| Total Assets | 578.65 |
| Total Current liabilities | 149.10 |
| Total Non Current Liabilities | 41.82 |
| Total Equity Plus Liabilities | 578.65 |
| Total Shareholder Funds | 350.99 |
| Total Debt to Equity | 7.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 18.18 |
| Cash from Financing Activities | 1.45 |
| Cash from Investing Activities | -15.03 |
| Net Cash Flow | 4.60 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages13
Bearish Moving Averages3
5 Day
922.1010 Day
913.8020 Day
862.1030 Day
816.2050 Day
796.60100 Day
753.60150 Day
721.40200 Day
722.60Indicators
RSI (14)
61.38MACD (12, 26)
42.49MACD Signal Line (9)
41.29MFI (14)
85.77ATR (14)
34.71ADX (14)
27.43ROC (21)
26.59ROC (125)
29.02Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 921.43 | 932.72 | 943.43 | 910.72 | 899.43 | 888.72 | 877.43 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Remus Pharmaceuticals Ltd.
REMUS
Open Price | 902.10 |
Prev Close | 910.15 |
Upper Circuit | 1,092.15 |
Lower Circuit | 728.15 |
Volume | 3,400 |
Average Traded Price | 919.63 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |